These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 8112382)

  • 21. Syntheses and binding studies of new [(aryl)(aryloxy)methyl]piperidine derivatives and related compounds as potential antidepressant drugs with high affinity for serotonin (5-HT) and norepinephrine (NE) transporters.
    Orjales A; Mosquera R; Toledo A; Pumar MC; García N; Cortizo L; Labeaga L; Innerárity A
    J Med Chem; 2003 Dec; 46(25):5512-32. PubMed ID: 14640559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo chronoamperometric measures of extracellular serotonin clearance in rat dorsal hippocampus: contribution of serotonin and norepinephrine transporters.
    Daws LC; Toney GM; Gerhardt GA; Frazer A
    J Pharmacol Exp Ther; 1998 Aug; 286(2):967-76. PubMed ID: 9694957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of long-term administration of duloxetine on the function of serotonin and noradrenaline terminals in the rat brain.
    Rueter LE; Kasamo K; de Montigny C; Blier P
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):600-10. PubMed ID: 9686935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of serotoninergic, noradrenergic, cholinergic and dopaminergic drugs on vigilance states in MPTP-treated mice.
    Laloux C; Derambure P; Jacquesson JM; Bordet R; Destée A; Monaca C
    Brain Res; 2007 Aug; 1161():79-87. PubMed ID: 17586479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Further studies on conformationally constrained tricyclic tropane analogues and their uptake inhibition at monoamine transporter sites: synthesis of (Z)-9-(substituted arylmethylene)-7-azatricyclo[4.3.1.0(3,7)]decanes as a novel class of serotonin transporter inhibitors.
    Zhang A; Zhou G; Hoepping A; Mukhopadhyaya J; Johnson KM; Zhang M; Kozikowski AP
    J Med Chem; 2002 Apr; 45(9):1930-41. PubMed ID: 11960503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of norepinephrine and serotonin transporter inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats.
    Davids E; Zhang K; Kula NS; Tarazi FI; Baldessarini RJ
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1097-102. PubMed ID: 12023542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attenuation by dopamine uptake blockers of the inhibitory effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and some of its analogs on NADH-linked metabolism in mouse neostriatal slices.
    Ofori S; Heikkila RE; Nicklas WJ
    J Pharmacol Exp Ther; 1989 Oct; 251(1):258-66. PubMed ID: 2571719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efflux studies allow further characterisation of the noradrenaline and 5-hydroxytryptamine transporters in rat lungs.
    James KM; Bryan-Lluka LJ
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):126-33. PubMed ID: 9228199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine.
    Owens MJ; Knight DL; Nemeroff CB
    Biol Psychiatry; 2001 Sep; 50(5):345-50. PubMed ID: 11543737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study.
    Beyer CE; Boikess S; Luo B; Dawson LA
    J Psychopharmacol; 2002 Dec; 16(4):297-304. PubMed ID: 12503828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conclusive evidence for distinct transporters for 5-hydroxytryptamine and noradrenaline in pulmonary endothelial cells of the rat.
    Paczkowski NJ; Vuocolo HE; Bryan-Lluka LJ
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Mar; 353(4):423-30. PubMed ID: 8935709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Forced swimming test and fluoxetine treatment: in vivo evidence that peripheral 5-HT in rat platelet-rich plasma mirrors cerebral extracellular 5-HT levels, whilst 5-HT in isolated platelets mirrors neuronal 5-HT changes.
    Bianchi M; Moser C; Lazzarini C; Vecchiato E; Crespi F
    Exp Brain Res; 2002 Mar; 143(2):191-7. PubMed ID: 11880895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uptake and release of norepinephrine by serotonergic terminals in norepinephrine transporter knock-out mice: implications for the action of selective serotonin reuptake inhibitors.
    Vizi ES; Zsilla G; Caron MG; Kiss JP
    J Neurosci; 2004 Sep; 24(36):7888-94. PubMed ID: 15356201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of cocaine effect on dopamine clearance in the core and shell of the nucleus accumbens of dopamine transporter knock-out mice.
    Budygin EA; John CE; Mateo Y; Jones SR
    J Neurosci; 2002 May; 22(10):RC222. PubMed ID: 12006604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of 3 beta-aryl-8-azabicyclo[3.2.1]octanes with high binding affinities and selectivities for the serotonin transporter site.
    Davies HM; Kuhn LA; Thornley C; Matasi JJ; Sexton T; Childers SR
    J Med Chem; 1996 Jun; 39(13):2554-8. PubMed ID: 8691453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thiophene derivatives: a new series of potent norepinephrine and serotonin reuptake inhibitors.
    Zhang A; Zhou G; Rong SB; Johnson KM; Zhang M; Kozikowski AP
    Bioorg Med Chem Lett; 2002 Apr; 12(7):993-5. PubMed ID: 11909701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biaryl analogues of conformationally constrained tricyclic tropanes as potent and selective norepinephrine reuptake inhibitors: synthesis and evaluation of their uptake inhibition at monoamine transporter sites.
    Zhou J; Zhang A; Kläss T; Johnson KM; Wang CZ; Ye YP; Kozikowski AP
    J Med Chem; 2003 May; 46(10):1997-2007. PubMed ID: 12723962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microautoradiography of [123I]ADAM in mice treated with fluoxetine and serotonin reuptake inhibitors.
    Ye XX; Chen JC; Liu RS; Wey SP; Lee JS; Chen CC; Fu YK; Ting G; Hwang JJ
    Nucl Med Biol; 2004 Jul; 31(5):557-62. PubMed ID: 15219272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age-associated changes in the densities of presynaptic monoamine transporters in different regions of the rat brain from early juvenile life to late adulthood.
    Moll GH; Mehnert C; Wicker M; Bock N; Rothenberger A; Rüther E; Huether G
    Brain Res Dev Brain Res; 2000 Feb; 119(2):251-7. PubMed ID: 10675775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced efficacy of fluoxetine following MDMA ("Ecstasy")-induced serotonin loss in rats.
    Durkin S; Prendergast A; Harkin A
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1894-901. PubMed ID: 18824064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.